224 related articles for article (PubMed ID: 12358998)
1. Treatment of asthmatic patients with a cysteinyl leukotriene receptor-1 antagonist montelukast (Singulair), decreases the eosinophil survival-enhancing activity produced by peripheral blood mononuclear leukocytes in vitro.
Becler K; Håkansson L; Rak S
Allergy; 2002 Nov; 57(11):1021-8. PubMed ID: 12358998
[TBL] [Abstract][Full Text] [Related]
2. Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells.
Virchow JC; Faehndrich S; Nassenstein C; Bock S; Matthys H; Luttmann W
Clin Exp Allergy; 2001 Jun; 31(6):836-44. PubMed ID: 11422147
[TBL] [Abstract][Full Text] [Related]
3. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
[TBL] [Abstract][Full Text] [Related]
4. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
5. A review of montelukast in the treatment of asthma and allergic rhinitis.
Nayak A
Expert Opin Pharmacother; 2004 Mar; 5(3):679-86. PubMed ID: 15013935
[TBL] [Abstract][Full Text] [Related]
6. Effect of cysteinyl leukotriene receptor antagonist on CD11b and CD23 expression in asthmatic children.
Gagro A; Aberle N; Rabatić S; Ajduk J; Jelacić J; Dekaris D
Clin Exp Allergy; 2004 Jun; 34(6):939-44. PubMed ID: 15196283
[TBL] [Abstract][Full Text] [Related]
7. Effects of ONO-1078 (pranlukast) on cytokine production in peripheral blood mononuclear cells of patients with bronchial asthma.
Tohda Y; Nakahara H; Kubo H; Haraguchi R; Fukuoka M; Nakajima S
Clin Exp Allergy; 1999 Nov; 29(11):1532-6. PubMed ID: 10520082
[TBL] [Abstract][Full Text] [Related]
8. Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT(1)R antagonism.
Robinson AJ; Kashanin D; O'Dowd F; Williams V; Walsh GM
J Leukoc Biol; 2008 Jun; 83(6):1522-9. PubMed ID: 18332235
[TBL] [Abstract][Full Text] [Related]
9. Montelukast inhibits interleukin-5 mRNA expression and cysteinyl leukotriene production in ragweed and mite-stimulated peripheral blood mononuclear cells from patients with asthma.
Frieri M; Therattil J; Wang SF; Huang CY; Wang YC
Allergy Asthma Proc; 2003; 24(5):359-66. PubMed ID: 14619337
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum eosinophilic cationic protein (ECP), soluble interleukin 2 receptor (sIL-2R), IL-4, and soluble intercellular adhesion molecule 1 (sICAM-1) in children with asthma.
Stelmach I; Jerzynska J; Kuna P
J Allergy Clin Immunol; 2002 Feb; 109(2):257-63. PubMed ID: 11842294
[TBL] [Abstract][Full Text] [Related]
11. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial.
Pizzichini E; Leff JA; Reiss TF; Hendeles L; Boulet LP; Wei LX; Efthimiadis AE; Zhang J; Hargreave FE
Eur Respir J; 1999 Jul; 14(1):12-8. PubMed ID: 10489822
[TBL] [Abstract][Full Text] [Related]
12. The effect of montelukast on eosinophil apoptosis: induced sputum findings of patients with mild persistent asthma.
Abadoglu O; Mungan D; Aksu O; Erekul S; Misirligil Z
Allergol Immunopathol (Madr); 2005; 33(2):105-11. PubMed ID: 15808118
[TBL] [Abstract][Full Text] [Related]
13. The effect of treatment with montelukast on in vitro interleukin-10 production of mononuclear cells of children with asthma.
Stelmach I; Majak P; Jerzynska J; Kuna P
Clin Exp Allergy; 2005 Feb; 35(2):213-20. PubMed ID: 15725194
[TBL] [Abstract][Full Text] [Related]
14. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
[TBL] [Abstract][Full Text] [Related]
15. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
16. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.
Stelmach I; Jerzynska J; Kuna P
Clin Exp Allergy; 2002 Feb; 32(2):264-9. PubMed ID: 11929492
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
[TBL] [Abstract][Full Text] [Related]
19. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
20. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast.
Minoguchi K; Kohno Y; Minoguchi H; Kihara N; Sano Y; Yasuhara H; Adachi M
Chest; 2002 Mar; 121(3):732-8. PubMed ID: 11888953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]